British journal of Cancer |
A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma |
Jan. 19 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab |
oct. 16 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours |
sep. 17 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma |
mai. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP) |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
British journal of Cancer |
Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response. |
Jan. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study |
Jan. 17 |
3 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men |
aoû. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab |
juin. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial |
oct. 17 |
3 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Text-message Reminders in Colorectal Cancer Screening (TRICCS): a randomised controlled trial |
mai. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients |
oct. 17 |
3 ♥ |
Cancers autres |
British journal of Cancer |
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
British journal of Cancer |
Efficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient data |
juin. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer |
juin. 16 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity |
mai. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib |
oct. 17 |
3 ♥ |
Cancers autres |
British journal of Cancer |
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2) |
sep. 15 |
2 ♥ |
Cancers autres (hors CCR et CHC), Œsophage/Estomac |
British journal of Cancer |
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma |
Jan. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer |
juin. 16 |
|
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project |
juin. 17 |
2 ♥ |
Cancer colorectal (CCR) |